• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄热病病毒RNA聚合酶的高保真度。

High fidelity of yellow fever virus RNA polymerase.

作者信息

Pugachev Konstantin V, Guirakhoo Farshad, Ocran Simeon W, Mitchell Fred, Parsons Megan, Penal Caroline, Girakhoo Soheila, Pougatcheva Svetlana O, Arroyo Juan, Trent Dennis W, Monath Thomas P

机构信息

Acambis, Inc., Cambridge, Massachusetts 02139, USA.

出版信息

J Virol. 2004 Jan;78(2):1032-8. doi: 10.1128/jvi.78.2.1032-1038.2004.

DOI:10.1128/jvi.78.2.1032-1038.2004
PMID:14694136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC368746/
Abstract

Three consecutive plaque purifications of four chimeric yellow fever virus-dengue virus (ChimeriVax-DEN) vaccine candidates against dengue virus types 1 to 4 were performed. The genome of each candidate was sequenced by the consensus approach after plaque purification and additional passages in cell culture. Our data suggest that the nucleotide sequence error rate for SP6 RNA polymerase used in the in vitro transcription step to initiate virus replication was as high as 1.34 x 10(-4) per copied nucleotide and that the error rate of the yellow fever virus RNA polymerase employed by the chimeras for genome replication in infected cells was as low as 1.9 x 10(-7) to 2.3 x 10(-7). Clustering of beneficial mutations that accumulated after multiple virus passages suggests that the N-terminal part of the prM protein, a specific site in the middle of the E protein, and the NS4B protein may be essential for nucleocapsid-envelope interaction during flavivirus assembly.

摘要

对四种针对1至4型登革病毒的嵌合黄热病病毒 - 登革病毒(ChimeriVax - DEN)候选疫苗进行了三轮连续的蚀斑纯化。在蚀斑纯化以及在细胞培养中进行额外传代后,通过一致性方法对每个候选疫苗的基因组进行测序。我们的数据表明,用于启动病毒复制的体外转录步骤中使用的SP6 RNA聚合酶的核苷酸序列错误率高达每复制一个核苷酸1.34×10⁻⁴,而嵌合体用于在受感染细胞中进行基因组复制的黄热病病毒RNA聚合酶的错误率低至1.9×10⁻⁷至2.3×10⁻⁷。多次病毒传代后积累的有益突变的聚类表明,prM蛋白的N端部分、E蛋白中间的一个特定位点以及NS4B蛋白可能对于黄病毒组装过程中的核衣壳 - 包膜相互作用至关重要。

相似文献

1
High fidelity of yellow fever virus RNA polymerase.黄热病病毒RNA聚合酶的高保真度。
J Virol. 2004 Jan;78(2):1032-8. doi: 10.1128/jvi.78.2.1032-1038.2004.
2
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.重组嵌合黄热-登革2型病毒在非人灵长类动物中具有免疫原性和保护性。
J Virol. 2000 Jun;74(12):5477-85. doi: 10.1128/jvi.74.12.5477-5485.2000.
3
Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.嵌合黄热病-登革热病毒四价疫苗制剂在非人灵长类动物中的安全性和有效性。
J Virol. 2004 May;78(9):4761-75. doi: 10.1128/jvi.78.9.4761-4775.2004.
4
Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response.嵌合黄热病/登革热病毒作为候选登革热疫苗:登革热病毒特异性CD8 T细胞反应的定量分析
J Virol. 2000 Sep;74(17):8094-101. doi: 10.1128/jvi.74.17.8094-8101.2000.
5
A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.嵌合黄热病-登革热1型疫苗病毒包膜蛋白中的单个氨基酸取代降低了对乳鼠的神经毒力以及对猴子的病毒血症/嗜内脏性。
J Virol. 2004 Sep;78(18):9998-10008. doi: 10.1128/JVI.78.18.9998-10008.2004.
6
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.四价黄热病-登革热嵌合疫苗在非人灵长类动物中的病毒血症和免疫原性:基因重组、剂量调整及针对野生型登革病毒分离株的抗体反应
Virology. 2002 Jun 20;298(1):146-59. doi: 10.1006/viro.2002.1462.
7
Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction.通过实时逆转录聚合酶链反应分析嵌合黄病毒疫苗-登革热1、2、3、4型四价病毒混合物在埃及伊蚊中的复制动力学。
Am J Trop Med Hyg. 2004 Jan;70(1):89-97.
8
Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.黄热病毒/登革2型病毒和黄热病毒/登革4型病毒嵌合体:在小鼠模型中的生物学特性、免疫原性及对登革脑炎的保护作用
J Virol. 2003 Mar;77(6):3655-68. doi: 10.1128/jvi.77.6.3655-3668.2003.
9
Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines.用于定量黄热病和嵌合黄热病-登革热疫苗的标准化定量逆转录聚合酶链反应检测法。
J Virol Methods. 2008 Jul;151(1):40-6. doi: 10.1016/j.jviromet.2008.03.026. Epub 2008 May 22.
10
Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.基于嵌合黄热病/登革热病毒的登革热疫苗的遗传稳定性。
Vaccine. 2011 Sep 2;29(38):6629-35. doi: 10.1016/j.vaccine.2011.06.101. Epub 2011 Jul 13.

引用本文的文献

1
Yellow Fever Virus Bank Production in Stationary Cell Culture.黄热病病毒在固定细胞培养中的生产
Methods Mol Biol. 2025;2913:223-230. doi: 10.1007/978-1-0716-4458-4_20.
2
The Last Universal Common Ancestor of Ribosome-Encoding Organisms: Portrait of LUCA.核糖体编码生物的最后一个普遍共同祖先:LUCA 画像。
J Mol Evol. 2024 Oct;92(5):550-583. doi: 10.1007/s00239-024-10186-9. Epub 2024 Aug 19.
3
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine.用于高产活YF17D载体寨卡疫苗的并行多因素工艺优化与强化
Vaccines (Basel). 2024 Jul 9;12(7):755. doi: 10.3390/vaccines12070755.
4
Utilization of nanopore direct RNA sequencing to analyze viral RNA modifications.利用纳米孔直接RNA测序分析病毒RNA修饰。
mSystems. 2024 Feb 20;9(2):e0116323. doi: 10.1128/msystems.01163-23. Epub 2024 Jan 31.
5
Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine.基因组多样性导致黄热病法国嗜神经病毒株疫苗具有神经侵袭性。
NPJ Vaccines. 2021 Apr 26;6(1):64. doi: 10.1038/s41541-021-00318-3.
6
Rapid generation of inoculum of a plant RNA virus using overlap PCR.利用重叠 PCR 快速生成植物 RNA 病毒的接种体。
Virology. 2021 Jan 15;553:46-50. doi: 10.1016/j.virol.2020.11.001. Epub 2020 Nov 13.
7
Limited evolution of the yellow fever virus 17d in a mouse infection model.黄热病毒 17d 在小鼠感染模型中的有限进化。
Emerg Microbes Infect. 2019;8(1):1734-1746. doi: 10.1080/22221751.2019.1694394.
8
Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus.黄热病:整合当前知识与技术创新以确定控制一种再度流行病毒的策略
Viruses. 2019 Oct 17;11(10):960. doi: 10.3390/v11100960.
9
A review of Dengvaxia®: development to deployment.登革热疫苗(Dengvaxia®):从研发到应用的综述。
Hum Vaccin Immunother. 2019;15(10):2295-2314. doi: 10.1080/21645515.2019.1658503. Epub 2019 Oct 7.
10
RNA Virus Fidelity Mutants: A Useful Tool for Evolutionary Biology or a Complex Challenge?RNA 病毒保真度突变体:进化生物学的有用工具还是复杂的挑战?
Viruses. 2018 Nov 1;10(11):600. doi: 10.3390/v10110600.

本文引用的文献

1
Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus.丙型肝炎病毒的非结构蛋白前体NS4A/B会改变宿主分泌器官的功能和超微结构。
J Virol. 2003 Jul;77(14):7843-55. doi: 10.1128/jvi.77.14.7843-7855.2003.
2
Topology of the membrane-associated hepatitis C virus protein NS4B.膜相关丙型肝炎病毒蛋白NS4B的拓扑结构
J Virol. 2003 May;77(9):5428-38. doi: 10.1128/jvi.77.9.5428-5438.2003.
3
West Nile virus vaccine.西尼罗河病毒疫苗
Curr Drug Targets Infect Disord. 2001 May;1(1):37-50. doi: 10.2174/1568005013343254.
4
Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly.黄病毒库京(Kunjin)NS3和NS5蛋白的互补分析确定了形成复制复合体所必需的最小区域,并表明NS3在顺式作用中对病毒组装是必需的。
J Virol. 2002 Nov;76(21):10766-75. doi: 10.1128/jvi.76.21.10766-10775.2002.
5
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.四价黄热病-登革热嵌合疫苗在非人灵长类动物中的病毒血症和免疫原性:基因重组、剂量调整及针对野生型登革病毒分离株的抗体反应
Virology. 2002 Jun 20;298(1):146-59. doi: 10.1006/viro.2002.1462.
6
Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum.蜱传脑炎病毒包膜蛋白prM和E在内质网中的折叠与二聚化
J Virol. 2002 Jun;76(11):5480-91. doi: 10.1128/jvi.76.11.5480-5491.2002.
7
Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.黄热病病毒非结构蛋白NS2A中的突变可选择性地阻断感染性颗粒的产生。
J Virol. 2002 May;76(10):4773-84. doi: 10.1128/jvi.76.10.4773-4784.2002.
8
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.登革病毒的结构:对黄病毒的组装、成熟及融合的影响
Cell. 2002 Mar 8;108(5):717-25. doi: 10.1016/s0092-8674(02)00660-8.
9
Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence.蜱传脑炎病毒的衣壳蛋白C能耐受大量内部缺失,是减毒的理想靶点。
J Virol. 2002 Apr;76(7):3534-43. doi: 10.1128/jvi.76.7.3534-3543.2002.
10
Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.嵌合黄病毒疫苗(ChimeriVax)的临床原理验证:针对黄病毒感染的重组减毒活疫苗。
Vaccine. 2002 Jan 15;20(7-8):1004-18. doi: 10.1016/s0264-410x(01)00457-1.